Intellectus Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$479K	Buy	136,446 +4,000	+3%	+$12.8K	0.1%	202
2025 Q4	$362K	Buy	132,446 +1,384	+1%	+$3.2K	0.07%	216
2025 Q3	$284K	Hold	131,062	–	–	0.06%	245
2025 Q2	$225K	Buy	131,062 +14,850	+13%	+$37K	0.05%	254
2025 Q1	$387K	Buy	116,212 +1,300	+1%	+$6.7K	0.1%	208
2024 Q4	$850K	Buy	114,912 +1,583	+1%	+$14.7K	0.19%	147
2024 Q3	$1.06M	Sell	113,329 -600	-0.5%	-$5.68K	0.27%	108
2024 Q2	$914K	Sell	113,929 -4,000	-3%	-$42.9K	0.25%	111
2024 Q1	$1.75M	Buy	117,929 +1,250	+1%	+$14.5K	0.46%	62
2023 Q4	$949K	Sell	116,679 -3,600	-3%	-$18.8K	0.27%	103
2023 Q3	$547K	Buy	120,279 +250	+0.2%	+$1.63K	0.17%	163
2023 Q2	$845K	Buy	120,029 +11,150	+10%	+$79.8K	0.25%	120
2023 Q1	$665K	Buy	108,879 +21,229	+24%	+$146K	0.21%	137
2022 Q4	$560K	Buy	87,650 +41,673	+91%	+$325K	0.2%	155
2022 Q3	$440K	Hold	45,977	–	–	0.16%	168
2022 Q2	$508K	Buy	45,977 +8,377	+22%	+$110K	0.17%	162
2022 Q1	$626K	Sell	37,600 -2,500	-6%	-$38.7K	0.19%	143
2021 Q4	$766K	Sell	40,100 -18,700	-32%	-$412K	0.2%	139
2021 Q3	$1.45M	Buy	58,800 +750	+1%	+$17.7K	0.35%	76
2021 Q2	$1.51M	Buy	58,050 +15,500	+36%	+$403K	0.34%	75
2021 Q1	$1.35M	Buy	42,550 +950	+2%	+$39.4K	0.37%	73
2020 Q4	$1.93M	Buy	41,600 +6,850	+20%	+$272K	0.58%	45
2020 Q3	$1.14M	Buy	34,750 +5,015	+17%	+$154K	0.43%	67
2020 Q2	$816K	Buy	29,735 +17,900	+151%	+$588K	0.32%	95
2020 Q1	$354K	Buy	11,835 +3,100	+35%	+$82.2K	0.17%	147
2019 Q4	$242K	Buy	+8,735	New	+$199K	0.1%	181